• Publications
  • Influence
Immunoterapia topica del carcinoma vescicale con KLH (keyhole limpet hemocyanin): studio controllato di fase 2
KLH appears active and non-toxic, and the result of a controlled study on patients with carcinoma in-situ is reported, indicating that KLH appears promising in the topical treatment of superficial bladder cancer.
Epirubicina ad alte dosi: vantaggi di un trattamento dilazionato
In conclusion, the split, high-dose treatment with intravesical epirubicin of superficial bladder cancer with intermediate risk was well tolerated in terms of side effects and was effective.